Herbridge, 28 Feb.2010_The production technologies used to extract sodium copper chlorophyllin from mulberry leaf or banana leaf are still in research and development in China. Sodium copper chlorophyllin is mainly extracted from silkworm excrement which is expanding application in recent years. Like other herbal extracts, sodium copper chlorophyllin also sees higher prices in China.
In addition to producing sodium copper chlorophyllin, silkworm excrement is also used to produce health pillow. This means that sodium copper chlorophyllin manufacturers have to compete with health pillow manufacturers to purchase silkworm excrement. Silkworm raisers prefer to sell silkworm excrement to pillow manufacturers who offer higer prices and volumes. The higher prices of silkworm excrement drive the prices of sodium copper chlorophyllin(Enterprise Standard) to rise to around 870RMB/kg in China. The market is stable now.
The combination of small profit space and higher raw materials costs as well as complicated extraction technologies restrains the development of sodium copper chlorophyllin market. There are only a few manufacturers to supply sodium copper chlorophyllin in China. In addition, sodium copper chlorophyllin is primarily for domestic market with stable demand. Owing to its non-plant sources, sodium copper chlorophyllin is not accepted in overseas market.
Copyright: www.herbridge.com
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

